Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic profile of Myfortic (enteric coated mycophenolate sodium) in a rapid steroid withdrawal protocol in combination with tacrolimus in stable renal transplant recipients in the fed and fasting state

Trial Profile

Pharmacokinetic profile of Myfortic (enteric coated mycophenolate sodium) in a rapid steroid withdrawal protocol in combination with tacrolimus in stable renal transplant recipients in the fed and fasting state

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 May 2016

At a glance

  • Drugs Mycophenolate sodium; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 11 Mar 2011 Planned end date changed from Dec 2008 to Jul 2011 as reported by ClinicalTrials.gov.
    • 11 Mar 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top